Ranitidine
- Product NDC
- 55289-319
- 11-digit product format
- 552890319
- Labeler code
- 55289
- Product ID
- 55289-319_8aad2255-4809-c1f8-e053-2a95a90a8a76
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ranitidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Application
- ANDA077824
- Marketing category
- ANDA
- Marketing start
- 2009-12-16
- Marketing end
- 0000-00-00
- Substance
- RANITIDINE HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 55289-319-01 | EA - Each | 55289-319 | ba0485fc-78eb-4c39-b090-d3971c1fd9e8 | 1 | 2013-02-13 |
| 55289-319-06 | EA - Each | 55289-319 | 87bb1402-910e-4c7d-82a0-2cec37c50001 | 1 | 2013-02-13 |
| 55289-319-10 | EA - Each | 55289-319 | e7abb69b-5eb8-46f4-9a30-9d6561714eb4 | 1 | 2013-02-13 |
| 55289-319-14 | EA - Each | 55289-319 | aef4cdbf-fdf1-46ce-88c1-42794a8646e3 | 1 | 2013-02-13 |
| 55289-319-15 | EA - Each | 55289-319 | bd9bf0fe-af0e-4245-86e1-25825fa4d5f4 | 1 | 2013-02-13 |
| 55289-319-20 | EA - Each | 55289-319 | 92d1a7f5-9e86-45d4-9804-d42f16b342f4 | 1 | 2013-02-13 |
| 55289-319-28 | EA - Each | 55289-319 | be938e6a-90fc-4486-9f79-220731c69bb0 | 1 | 2013-02-13 |
| 55289-319-30 | EA - Each | 55289-319 | 7d69b8d5-1416-4459-b9c7-936dce5c5bc4 | 1 | 2013-02-13 |
| 55289-319-60 | EA - Each | 55289-319 | 18a47558-c5a1-4817-9853-2030a389a84a | 1 | 2013-02-13 |
| 55289-319-90 | EA - Each | 55289-319 | 1d413310-eea7-4490-a961-47c5e2fa8398 | 1 | 2013-02-13 |
| 55289-319-93 | EA - Each | 55289-319 | 65f89f62-0a25-4f82-a5b6-992569b2deda | 1 | 2013-02-13 |